Peri-operative Vitamin D Therapy for Hepatectomy

Peri-operative Vitamin D Therapy for Patients With Hepatocellular Carcinoma Receiving Hepatectomy

The goal of this double-blind, randomized controlled trial is to test the effect of short-term and high-dose vitamin D therapy in patients undergoing hepatectomy for hepatocellular carcinoma.

Participants will receive short-term high dose of vitamin D during perioperative period.

The main questions the study aims to answer are:

1. If vitamin D therapy benefits perioperative care
2. If short-term high dose of vitamin D supplement is safe

Inclusion Criteria:

• Patients older than 20 years
• Patients will undergo hepatectomy for hepatocellular carcinoma.

Exclusion Criteria:

• Patients with hypercalcemia, hyperparathyroidism, sarcoidosis, multiple myeloma